Year
2025202420232022202120202019201820172016201420132012201120102009200820072006200520042003200220012000
Edition number
№20 (313)№19 (311)№18 (311)№s4-15№17 (310)№16 (309)№15 (308)№14 (307)№13 (306)№s3-15№12 (305)№11 (304)№10 (303)№9 (302)№s2-15№8 (301)№6 (299)№5 (298)№s1-15№4 (297)№3 (296)№2 (295)№1 (294)
№7 (300) / 2015
T.V. Beketova
STANDARD INDUCTION THERAPY OF ANCA-ASSOCIATED SYSTEMIC VASCULITeS: MYTHS AND REALITIES7-13
S.N. Ivanov (1), A.Yu. Kochish (1), L.B. Reznik (2), E.V. Sannikova (1)
VIEW OF ORTHOPEDIST-TRAUMATOLOGIST ON THE POSSIBILITY OF USING TERIPARATIDE IN PATIENTS WITH OSTEOPOROTIC BONE FRACTURES14-20
T.V. Korotaeva
ADVANCES IN THE TREATMENT OF PSORIATIC ARTHRITIS21-27
V.A. Golovacheva, V.A. Parfenov
HOW WE CAN HELP PATIENTS WITH CHRONIC DAILY HEADACHE?28-32
G.I. Guliyeva
CLINICAL EFFICACY OF CHONDROGARD IN THERAPY OF OSTEOARTHROSIS33-36
M.R. Kuznetsov (1), A.V. Karalkin (2), A.I. Fedin (3), A.O. Virgansky (1), N.V. Kunitsyn (2), E.A. Kholopova (4), S.M. Yumin (1)
POTENTIALS FOR THE PHARMACOLOGICAL PRECONDITIONING IN THE SURGICAL TREATMENT OF HEMODYNAMICALLY SIGNIFICANT CAROTID STENOSIS37-44
V.V. Mashin, L.A. Belova, A.N. Proshin, V.V. Abramova
INFLUENCE OF THERAPY WITH CORTEXIN® ON THE RISK OF DEVELOPMENT OF MODS IN ISCHEMIC STROKE45-50
L.N.Gorobets, A.G.Lorikyan
STATE OF HYPOTHALAMIC-PITUITARY-ADRENAL SYSTEM IN PATIENTS WITH FIRST PSYCHOTIC EPISODE DURING ANTIPSYCHOTIC THERAPY WITH OLANZAPINE51-55
V.V. Ryazhenov (1, 2), S.G. Gorokhov (2, 3), E.R. Volkova (2)
PHARMACOECONOMIC ANALYSIS OF DIFFERENT STRATEGIES OF MONOTHERAPY WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS56-60
A.A. Godzenko
MODERN POTENTIALS FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS61-65
N.M. Bulanov, P.I. Novikov
POTENTIALS FOR THE USE OF LORNOXICAM IN THE TREATMENT OF OSTEOARTHROSIS66-71
V.A. Parfenov, A.A. Naumenko, I.S. Preobrazhenskaya
MEDICAL AND DRUG-FREE METHODS OF TREATMENT OF ALZHEIMER'S DISEASE72-79
L.N. Gorobets, A.V. Litvinov, L.M. Vasilenko, G.P. Ivanova, V.S. Bulanov, M.A. Tsarenko
GENDER DIFFERENCES IN ANTIPSYCHOTIC TREATMENT OF PATIENTS WITH SCHIZOPHRENIA-RELATED DISORDERS: ENDOCRINOLOGICAL ASPECTS80-86
S.G. Anikin, T.A. Korotkova
THE USE OF ALENDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS87-90
N.V. Fedorova, T.K. Kulua
APPLICATION OF LONG ACTING PRAMIPEXOLE AT ADVANCED STAGE OF PARKINSON'S DISEASE. CASE REPORTS91-95
